DudeDiligence.

FINANCING

Who is raising money: selling new shares, filing room to sell more later, or borrowing. New shares give every holder a smaller slice.

Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing

Key

Shares soldSold over timeRoom to sell laterBorrowingReverse splitThe stock since the filing

Newest first. A company with several filings is one row; open it for each.

  1. FDUSFidus Investment CorporationAt-the-market programme, with Raymond James & Associates$400.0M55% of value−6.6%424B3 ↗
  2. VSTMVerastem, Inc.At-the-market programme, with Cantor Fitzgerald$100.0M13% of value−32.5%S-3ASR ↗
  3. FATEFate Therapeutics, Inc.At-the-market programme$100.0M89% of value−50.3%
  4. AVTXAvalo Therapeutics, Inc.At-the-market programme$200.0M51% of value−4.4%
  5. DDD3D Systems CorporationAt-the-market programme$42.5M17% of value−48.9%
  6. BIVIBioVie Inc.At-the-market programme$6.5M75% of value−40.3%
  7. QNRXQuoin Pharmaceuticals, Ltd.At-the-market programme, with Leerink Partners$11.0M70% of value−18.4%424B5 ↗
  8. DSGNDesign Therapeutics, Inc.At-the-market programme$200.0M35% of value−15.1%424B5 ↗
  9. ARVNArvinas, Inc.At-the-market programme, with Piper Sandler$200.0M47% of value−8.9%S-3 ↗
  10. OCSOculis Holding AGAt-the-market programme, with Leerink Partners$100.0M25% of value−7.5%424B5 ↗
  11. CSWCCapital Southwest CorporationAt-the-market programme, with RBC Capital Markets$2.00B1.3x value−3.7%424B3 ↗
  12. MSTRStrategy IncAt-the-market programme$21.00B64% of value−40.4%
  13. BLNKBlink Charging Co.At-the-market programme, with H.C. Wainwright$100.0M2.1x value−19.5%S-3 ↗
  14. APVOAptevo Therapeutics Inc.At-the-market programme$2.3M1.6x value−69.8%424B5 ↗
  15. XELXcel Energy Inc.At-the-market programme, with Barclays Capital$6.00B12% of value−0.7%424B5 ↗
  16. PLDPrologis, Inc.At-the-market programme, with BTIG$5.00B4.2% of value−4.3%424B5 ↗
  17. VORVor Biopharma Inc.At-the-market programme, with William Blair$150.0M13% of value−8.2%424B5 ↗
  18. PROKProKidney Corp.At-the-market programme$200.0M48% of value−29.3%
  19. BFLYButterfly Network, Inc.At-the-market programme, with TD Securities (USA)$150.0M10% of value−30.9%S-3ASR ↗
  20. EQIXEquinix, Inc.At-the-market programme, with Barclays Capital$700.0M0.7% of value−3.4%S-3ASR ↗
  21. AURAurora Innovation, Inc.At-the-market programme$1.17B17% of value−31.1%424B5 ↗
  22. CTOCTO Realty Growth, Inc.At-the-market programme, with BofA Securities$89.5M12% of value+3.2%424B5 ↗
  23. OSSOne Stop Systems, Inc.At-the-market programme$50.0M50% of value−40.7%
  24. XXII22nd Century Group, Inc.At-the-market programme$18.8M−94.5%
  25. ZURAZura Bio LimitedAt-the-market programme, with Leerink Partners$114.0M1.3x value−78.2%S-3 ↗
  26. PBKPowerBank CorporationAt-the-market programme$200.0M−48.0%F-3 ↗
  27. ASSTStrive, Inc.At-the-market programme, with Cantor Fitzgerald$1.00B54% of value−49.9%424B5 ↗
  28. EARNEllington Credit CompanyAt-the-market programme, with Citizens JMP Securities$125.0M1.3x value−31.0%424B3 ↗
  29. XPONExpion Energy, Inc.At-the-market programme, with H.C. Wainwright$1.7M84% of value−50.1%S-3 ↗
  30. IMRNImmuron LimitedAt-the-market programme$2.0M28% of value−5.6%424B5 ↗
  31. TRAWTraws Pharma, Inc.Equity line with Roth Principal Investments$50.0M−48.5%8-K ↗
  32. PINEAlpine Income Property Trust, Inc.At-the-market programme$150.0M51% of value+0.7%
  33. AXGSolowin HoldingsAt-the-market programme, with Chaince Securities$50.0M−95.0%424B5 ↗
  34. AEHLAntelope Enterprise Holdings LimitedAt-the-market programme$100.0M78% of value−26.0%424B5 ↗